Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Carrera Hueso

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Revista De Medicina De La Universidad De Navarra|July 27, 1999
[Health outcomes analysis and its applications]F J Carrera-Hueso
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 27, 2012
[Structural sensitivity analysis]F J Carrera-Hueso, A Ramón-Barrios
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 27, 2012
[Application of pharmacoeconomics in clinical management]M Amat Díaz, J L Poveda Andrés, F J Carrera-Hueso
European Review for Medical and Pharmacological Sciences|September 22, 2016
Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s diseaseR Sanjuan-Cervero, J E Poquet-Jornet, F J Carrera-Hueso
Vacunas|November 9, 2021
Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?D El-Qutob, M Nieto, L Alvarez-Arroyo, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 24, 2012
[Efficacy of a topical treatment protocol with dimethyl sulfoxide 50% in type 1 complex regional pain syndrome]M Gaspar, M Bovaira, F J Carrera-Hueso, et al.
The Bone & Joint Journal|January 7, 2018
Efficacy and adverse effects of collagenase use in the treatment of Dupuytren's disease: a meta-analysisR Sanjuan-Cerveró, F J Carrera-Hueso, P Vazquez-Ferreiro, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 27, 2012
[Pharmacoeconomic aspects of oral cytostatic agents]J E Poquet Jornet, F J Carrera-Hueso, J M Gasent Blesa, et al.
Revista Espanola De Cirugia Ortopedica Y Traumatologia (English Ed.)|March 10, 2018
One year follow-up after treatment with CCH for Dupuytren's disease: A prospective viewR Sanjuán-Cerveró, P Vazquez-Ferreiro, D Gómez-Herrero, et al.
Heart & Lung : the Journal of Critical Care|February 18, 2022
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxisD El-Qutob, L Alvarez-Arroyo, I Barreda, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Revista De Medicina De La Universidad De Navarra|July 27, 1999
[Health outcomes analysis and its applications]F J Carrera-Hueso
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 27, 2012
[Structural sensitivity analysis]F J Carrera-Hueso, A Ramón-Barrios
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 27, 2012
[Application of pharmacoeconomics in clinical management]M Amat Díaz, J L Poveda Andrés, F J Carrera-Hueso
European Review for Medical and Pharmacological Sciences|September 22, 2016
Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s diseaseR Sanjuan-Cervero, J E Poquet-Jornet, F J Carrera-Hueso
Vacunas|November 9, 2021
Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?D El-Qutob, M Nieto, L Alvarez-Arroyo, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 24, 2012
[Efficacy of a topical treatment protocol with dimethyl sulfoxide 50% in type 1 complex regional pain syndrome]M Gaspar, M Bovaira, F J Carrera-Hueso, et al.
The Bone & Joint Journal|January 7, 2018
Efficacy and adverse effects of collagenase use in the treatment of Dupuytren's disease: a meta-analysisR Sanjuan-Cerveró, F J Carrera-Hueso, P Vazquez-Ferreiro, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 27, 2012
[Pharmacoeconomic aspects of oral cytostatic agents]J E Poquet Jornet, F J Carrera-Hueso, J M Gasent Blesa, et al.
Revista Espanola De Cirugia Ortopedica Y Traumatologia (English Ed.)|March 10, 2018
One year follow-up after treatment with CCH for Dupuytren's disease: A prospective viewR Sanjuán-Cerveró, P Vazquez-Ferreiro, D Gómez-Herrero, et al.
Heart & Lung : the Journal of Critical Care|February 18, 2022
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxisD El-Qutob, L Alvarez-Arroyo, I Barreda, et al.
Pageof 2